[go: up one dir, main page]
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 2
2004 1
2007 1
2008 5
2009 7
2010 7
2011 13
2012 10
2013 5
2014 7
2015 3
2016 6
2017 5
2018 5
2019 11
2020 2
2021 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, et al. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
Rivaroxaban: searching the integral vascular protection.
Barrios V, Almendro-Delia M, Facila L, Garcia-Moll X, Mazón P, Camafort M, Cepeda JM, Mediavilla Garcia JD, Pose Reino A, Suarez Fernandez C. Barrios V, et al. Among authors: mazon p. Expert Rev Clin Pharmacol. 2018 Jul;11(7):719-728. doi: 10.1080/17512433.2018.1495559. Epub 2018 Jul 18. Expert Rev Clin Pharmacol. 2018. PMID: 29965791 Review.
Comments on the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension.
SEC Working Group for the 2018 ESC ESH Guidelines on Arterial Hypertension; Expert Reviewers for the 2018 ESC ESH Guidelines on Arterial Hypertension; SEC Guidelines Committee. SEC Working Group for the 2018 ESC ESH Guidelines on Arterial Hypertension, et al. Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):104-108. doi: 10.1016/j.rec.2018.12.001. Rev Esp Cardiol (Engl Ed). 2019. PMID: 30704721 English, Spanish. No abstract available.
Role of rivaroxaban in the prevention of atherosclerotic events.
Sanmartín M, Bellmunt S, Cosín-Sales J, García-Moll X, Riera-Mestre A, Almendro-Delia M, Hernández JL, Lozano F, Mazón P, Suarez Fernández C. Sanmartín M, et al. Among authors: mazon p. Expert Rev Clin Pharmacol. 2019 Aug;12(8):771-780. doi: 10.1080/17512433.2019.1637732. Epub 2019 Jul 9. Expert Rev Clin Pharmacol. 2019. PMID: 31269825 Review.
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.
McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, Christodorescu RM, Daskalopoulou SS, Ferro CJ, Gerdts E, Hanssen H, Harris J, Lauder L, McManus RJ, Molloy GJ, Rahimi K, Regitz-Zagrosek V, Rossi GP, Sandset EC, Scheenaerts B, Staessen JA, Uchmanowicz I, Volterrani M, Touyz RM; ESC Scientific Document Group. McEvoy JW, et al. Eur Heart J. 2024 Aug 30:ehae178. doi: 10.1093/eurheartj/ehae178. Online ahead of print. Eur Heart J. 2024. PMID: 39210715 No abstract available.
Update in cardiology: vascular risk and cardiac rehabilitation.
Galve E, Cordero A, Bertomeu-Martínez V, Fácila L, Mazón P, Alegría E, Fernández de Bobadilla J, García-Porrero E, Martínez-Sellés M, González-Juanatey JR. Galve E, et al. Among authors: mazon p. Rev Esp Cardiol (Engl Ed). 2015 Feb;68(2):136-43. doi: 10.1016/j.rec.2014.10.005. Epub 2015 Jan 9. Rev Esp Cardiol (Engl Ed). 2015. PMID: 25583549 Review.
Update in cardiology: vascular risk and cardiac rehabilitation.
Galve E, Alegría E, Cordero A, Fácila L, Fernández de Bobadilla J, Lluís-Ganella C, Mazón P, de Pablo Zarzosa C, González-Juanatey JR. Galve E, et al. Among authors: mazon p. Rev Esp Cardiol (Engl Ed). 2014 Mar;67(3):203-10. doi: 10.1016/j.rec.2013.09.019. Epub 2014 Jan 31. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774395 Review.
Comments on the ESC guidelines on the management of cardiovascular diseases during pregnancy. A critical vision of Spanish cardiology.
Alonso Gómez AM, Comín J, Borrás X, del Castillo S, Elvira González A, Mazón P, Monserrat L, Pijuan A, Salvador Sanz A; Grupo de Trabajo de Sociedad Española de Cardiología de Guía de Práctica Clínica sobre embarazo; Comité de Guías de Práctica Clínica de SEC; Anguita M, Cequier A, Fernández-Ortiz A, Pan M, Worner F, Alonso Gómez AM, Comín J, Alonso C, Bardají A, Cobo M, García-Pavía P, González Costello J, Oliver JM, Pedreira M, Serrano JM, Subirana M, Tornos P. Alonso Gómez AM, et al. Among authors: mazon p. Rev Esp Cardiol (Engl Ed). 2012 Feb;65(2):113-8. doi: 10.1016/j.recesp.2011.12.001. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22265198 English, Spanish. No abstract available.
Comments on the ESC guidelines on cardiovascular disease prevention (version 2012). A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology.
Diaz-Buschmann I, Castro A, Galve E, Calero MJ, Dalmau R, Guzmán G, Cordero A, Fácila L, Quiles J, Arrarte V, Diaz-Buschmann I, Alonso Gómez ÁM, Cequier Á, Comín J, Fernández-Ortiz A, Pan M, Fernández Lozano FW, Fernández-Ortiz A, Sanmartín M, Ferreira I, Brotons C, López Sendón JL, Mazón P, Alonso J, Abeytua M, González Juanatey JR, de Pablo C, Worner F, Castro-Beiras A; Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Diaz-Buschmann I, et al. Among authors: mazon p. Rev Esp Cardiol (Engl Ed). 2012 Oct;65(10):869-73. doi: 10.1016/j.recesp.2012.08.001. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22999109 English, Spanish. No abstract available.
85 results